Clinical Trial Update: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating IMNN-001 in combination with standard neoadjuvant and adjuvant chemotherapy for newly diagnosed advanced epithelial ovarian …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• IMNN-001 (GEN-1)

Snippet

Sponsor: Imunon | Conditions: Epithelial Ovarian Cancer, Ovarian Cancer | Phase 3 | Status: RECRUITING